TC
DICE

Trium Capital’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Trium Capital’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,600
Closed -$446 – 95
2023
Q2 		$446 Buy
+9,600
New +$332K 0.1% 57

Trium Capital's DICE Position: Q3 2023 in Review

Trium Capital sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 39,449 shares — an estimated $1.83K sold.

Trium Capital first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $1.83K in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Trium Capital reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Trium Capital sold 39,449 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.83K.
  • Trium Capital first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Trium Capital's DICE Therapeutics, Inc. Common Stock position peaked at $1.83K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Trium Capital's 13F filing for Q3 2023, filed 6 Nov 2023.